Nephris

Research and innovation for diabetic kidney disease

Milan, Italy · Founded 2021 · $3.2M raised

Headquarters
Milan
Employees
1–10
Founded
2021
Business Model
B2B
Total Funding
$3.2M
Last Round
$3.2M SeedApr 2022
Rounds
1

About

Nephris is a pre-clinical stage biotech company developing first-in-class therapies for chronic kidney disease in diabetic patients. Founded in 2021 in Milan by Dr. Paolo Fiorina, a professor of endocrinology at the University of Milan, and Dr. Francesca D'Addio, the company focuses on identifying novel pathogenic factors and therapeutic targets in diabetic nephropathy. Nephris is backed by Sofinnova Partners through the Sofinnova Telethon Fund, a fund dedicated to rare and genetic disease biotechnology, and is developing kidney-targeting drug delivery approaches to slow or reverse disease progression.

Summary

Nephris is a Biotech company based in Milan, Italy, founded in 2021. It has raised $3.2M in total across 1 round, most recently a $3.2M Seed round in Apr 2022. Investors include Sofinnova Partners.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundApr 2022
$3.2M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Nephris on Indexed.vc
<a href="https://indexed.vc/companies/nephris"><img src="https://indexed.vc/api/badge/company/nephris" alt="Nephris on Indexed.vc" width="260" height="76" /></a>